Patient Preferences for a Blood-Based Colorectal Cancer Screening Test: Insights From a Conjoint Analysis Survey
Open Access
- 27 October 2025
- journal article
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 17 (1) , e00945
Abstract
INTRODUCTION: Over one-third of people are not up-to-date with colorectal cancer (CRC) screening, and blood-based tests offer a promising alternative to existing options. We used conjoint analysis to quantify the proportion of people who would prefer a hypothetical blood test over current methods (e.g., fecal immunochemical test, multitarget stool DNA test, colonoscopy). METHODS: We conducted a conjoint analysis survey in a US nationally representative sample of average risk individuals aged 40–75 years who were not up-to-date with CRC screening. We performed latent class analysis to identify groups with similar decision-making profiles and estimated the proportion who would prefer a blood test every 3 years over existing methods. RESULTS: Overall, 1,009 participants completed the survey. Using latent class analysis, we identified 2 distinct groups: (i) prioritized how the test is performed—39.4%, and (ii) prioritized the accuracy of detecting CRC and advanced adenomas—60.6%. Through simulations using the conjoint data, most individuals in the first group preferred a blood test every 3 years (65.1%), whereas 53.0% of the second group also favored the blood test. In additional simulations that incorporated test accuracy for CRC and advanced adenoma detection, these performance characteristics emerged as important drivers of screening preferences across the different testing options. DISCUSSION: Among individuals not up-to-date with CRC screening, our findings suggest that many would generally prefer a blood-based screening test over other options, but preference may depend on test accuracy. Offering a blood test option may improve CRC screening uptake, particularly among individuals who are unscreened or overdue for screening.Keywords
Funding Information
- Freenome
This publication has 24 references indexed in Scilit:
- Clinical Validation of a Circulating Tumor DNA–Based Blood Test to Screen for Colorectal CancerJAMA, 2025
- Blood Test Increases Colorectal Cancer Screening in Persons Who Declined Colonoscopy and Fecal Immunochemical Test: A Randomized Controlled TrialClinical Gastroenterology and Hepatology, 2023
- Patient Preferences for Colorectal Cancer Screening Tests in Light of Lowering the Screening Age to 45 YearsClinical Gastroenterology and Hepatology, 2022
- Colorectal cancer screening preferences among physicians and individuals at average risk: A discrete choice experimentCancer Medicine, 2022
- Screening for Colorectal CancerJAMA, 2021
- Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal CancerJournal of General Internal Medicine, 2019
- Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes StudyJournal of General Internal Medicine, 2015
- Self-Reported Barriers to Colorectal Cancer Screening in a Racially Diverse, Low-Income Study PopulationJournal of Community Health, 2012
- Patient-Reported Barriers to Colorectal Cancer ScreeningAmerican Journal of Preventive Medicine, 2010
- The self‐administered comorbidity questionnaire: A new method to assess comorbidity for clinical and health services researchArthritis Care & Research, 2003